Latest Commercialisation News

Nanoveu Limited has accelerated its commercial and technological momentum with a $3.02 million capital raise, a breakthrough 33% increase in drone flight time using its edge-AI chip, and progress toward a U.S. OTCQB listing.

EMVision Medical Devices reports strong progress in its pivotal trial for the emu™ bedside brain scanner and successful aeromedical testing of its First Responder device, backed by a $5 million government grant and $10.5 million in cash reserves.

Parkway Corporate Limited reported a strong quarter with $4.22 million in revenue and $0.47 million EBITDA, driven by a major wastewater contract and progress in its innovative Queensland Brine Solutions technology.

McLaren Minerals has completed a major drilling phase at its McLaren Titanium Project, uncovering significant extensions to mineralised zones and validating key processing methods. The company also secured $1.28 million in an oversubscribed capital raise to fund next-stage development.

OncoSil Medical has reported a record 20% quarterly increase in dose sales and secured $8.7 million in new capital, underpinning its clinical and commercial expansion in pancreatic cancer treatment.

White Energy Company Limited reported promising exploration results across multiple Australian projects targeting critical minerals, alongside progress in commercialising its innovative coal briquetting technology in South Africa.

Patrys Limited has completed a modest capital raise and restructured its leadership as it advances its deoxymab antibody program, with a larger entitlement offer announced to fund clinical development and business growth.

Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.

Lion Energy has made steady progress on its Port of Brisbane Green Hydrogen Project while moving closer to securing funding for a key drilling operation in Indonesia’s East Seram PSC.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.

Prescient Therapeutics has raised $6.8 million through a Share Purchase Plan to fund the Phase 2 development of its novel cancer therapy PTX-100, while launching a discounted placement to sophisticated investors.

Atomo Diagnostics reports strong commercial momentum in Q4 FY25, highlighted by a major US supply agreement, rapid growth in HIV self-test sales, and promising data for its syphilis test.